LAHORE: Only three percent of cancer patients in Pakistan are diagnosed at an early and curable stage, while 22 percent are ...

Targeted Oncology connects oncology professionals with updates on immunotherapy, biomarkers, cancer pathways, and targeted ...

MSD Australia & New Zealand is astonished that after eight years of dialogue and consideration, the Pharmaceutical Benefits Advisory Committee (PBAC ...

Luke FaulksLocal Journalism Initiative ReporterPique NewsmagazineA Pemberton resident and her family are appealing to the ...

Bristol-Myers Squibb Company (($BMY)) announced an update on their ongoing clinical study. Study Overview: Bristol-Myers ...

The interventions being tested include Trastuzumab deruxtecan (T-DXd), an experimental therapy, combined with either Rilvegostomig or Pembrolizumab, both administered via intravenous infusion. These ...

"Prior to the EV-302 clinical trial, the treatment of advanced bladder cancer treatment hadn't significantly changed since ...

This article highlights recent research on breast cancer, lung cancer, melanoma, head and neck cancer, and hematologic malignancies.

A significant breakthrough in advanced bladder cancer treatment has been approved for use on the NHS, offering renewed hope ...

The VEGFR-2 inhibitors market is gaining significant traction, driven by the rising global burden of cancer and age-associated conditions suc ...

UCLA’s cancer research has been deeply impactful, with millions of people receiving drugs and therapies developed in Bruin ...